Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients

American Journal of Hypertension

Volumn 15, Issue 12, 2002, Pages 1042-1049

  Fogari, Roberto ^a,j   Preti, Paola ^a   Zoppi, Annalisa ^a   Rinaldi, Andrea ^a   Corradi, Luca ^b   Pasotti, Carlo ^c   Poletti, Luigi ^d   Marasi, GianLuigi ^e   Derosa, Giuseppe ^f   Mugellini, Amedeo ^g   Voglini, Carlo ^h   Lazzari, Pierangelo ⁱ  

^a UNIVERSITY OF PAVIA   (Italy)

^b Broni Stradella Hospital   (Italy)

^c Mede Hospital   (Italy)

^d Necchi Hypertension Center   (Italy)

^e Agusta Hypertension Center   (Italy)

^f Antidiabetic Ctr S Maria Hospital   (Italy)

^g Città di Pavia Veterinary Hospital   (Italy)

^h Mortara Hospital   (Italy)

ⁱ CREMONA HOSPITAL   (Italy)

^j FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

more..

Author keywords

Amlodipine; Diabetes; Fosinopril; Hypertension; Microalbuminuria

Indexed keywords

ALBUMIN; AMLODIPINE; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE CLEARANCE; DRUG EFFICACY; EDEMA; FEMALE; GLUCOSE HOMEOSTASIS; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ALBUMINURIA; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED;

AGED; ALBUMINURIA; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; FEMALE; FOSINOPRIL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0036892151     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03017-0     Document Type: Article

References (38)

1. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984;310:356-360.
2. Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Intern Med 1997;157:1413-1418.
3. Mogensen CE: Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med 1994;235:297-316.
4. Schmitz A, Vaeth M, Mogensen CE: Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994;37:1251-1258.
5. Parving HH, Rossing P: The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. Curr Opin Nephrol Hypertens 1994;3:292-300.
6. American Diabetes Association: Diabetic nephropathy. Diabetes Care 1998;20(Suppl 1):524-527.
7. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study. Arch Intern Med 1996;156:286-289.
8. Bretzel RG: Can we further slow down the progression to end-stage renal disease in diabetic hypertensive patients? J Hypertens 1997;15(Suppl 2):S83-S88.
9. Salvetti A, Mattei P, Sudano I: Renal protection and antihypertensive drugs: Current status. Drugs 1999;57:665-693.
10. Epstein M: Calcium-antagonists and renal protection: Emerging perspectives. J Hypertens 1998;16(Suppl 4):S17-S25.
11. Rugenenti P, Mosconi L, Bianchi L, Cortesi L, Campana M, Pagani G, Mecca G, Remuzzi G: Long-term treatment with either enalapril or nitrendipine stabilises albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. Am J Kidney Dis 1994;24:753-761.
12. Pinol C, Cobos A, Cases A, Esmatges E, Soler J, Closas J, Pascual R, Planas J: Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria. Kidney Int 1996;49(Suppl 55):S85-S87.
13. Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996;45:216-222.
14. Mosconi L, Ruggenenti P, Perna A, Mecca G, Remuzzi G: Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin-dependent diabetes. Kidney Int 1996;49(Suppl 55):S91-S93.
15. Fogari R, Zoppi A, Malamani GD, Lusardi P, Destro M, Corradi L: Effects of amlodipine vs enalapril on microalbuminuria in hypertensive patients with type II diabetes. Clin Drug Invest 1996;11 (Suppl):42-49.
16. Fogari R, Zoppi A, Corradi L, Poletti L, Pasotti M, Fogari E, Mugellini A: Long-term effects of amlodipine versus fosinopril on microalbuminuria in elderly hypertensive patients with type 2 diabetes mellitus. Curr Ther Res 2000;61:163-173.
17. Guazzi MD, DeCesare N, Galli C, Salvioni A, Tramontana C, Tamborini G, Bartorelli A: Calcium channel blockade with nifedipine and angiotensin converting enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation 1984;70:279-284.
18. Osswald H, Muhlbauer B: The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension. J Hypertens 1995;13(Suppl 2):S21-S28.
19. Fogari R, Zoppi A, Mugellini A, Lusardi P, Destro M, Corradi L: Effect of benazepril plus amlodipine vs benazepril alone on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria. Clin Drug Invest 1996;11(Suppl):50-55.
20. Shigihara T, Sato A, Hayashi K, Saruta T: Effect of combination therapy of angiotensin-converting-enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes. Hypertens Res 2000;23:219-226.
21. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;281:1039-1057.
22. Sowers JR, Reed J: Clinical advisory treatment of hypertension in diabetes. J Clin Hypertens 2000;2:132-133.
23. Joint National Committeee on Prevention Detection, Evaluation and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2416.
24. Zats R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner B: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
25. Amann K, Irzyenic T, Mall G, Ritz E: The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy: A stereological study. J Hypertens 1993;11:969-975.
26. Ritz E, Orth S, Strzelczyk P: Angiotensin converting enzyme inhibitors, calcium channel blockers and their combination in the treatment of glomerular disease. J Hypertens 1997;15(Suppl 2):S21-S26.
27. United Kingdom Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. Br Med J 1998;317:703-713.
28. American Diabetes Association: Clinical practice recommendations, 1999. Diabetes Care 1999;22(Suppl 1):S66-S69.
29. Loutzenhiser R, Epstein M: Effects of calcium antagonists on renal hemodynamics. Am J Physiol 1985;249:F619-F629.
30. Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T: Disparate effects of calcium antagonists on renal microcirculation. Hypertension Res 1996;19:31-36.
31. Orth SR, Nobiling R, Bonisch S, Ritz E: Inhibitory effect of calcium channel blockers on human mesangial cell growth: Evidence for actions independent of L-type Ca++ channels. Kidney Int 1996;49:868-879.
32. Schultz PJ, Raij L: Effect of amlodipine on mesangial cell proliferation and protein synthesis. Am J Hypertens 1992;5:912-914.
33. Rossing P, Hommel E, Smidt UM, Parving HH: Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 1994;45(Suppl 45):S145-S149.
34. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P, for the Irbesartan in patients with type 2 diabetes and microalbuminuria study group: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878.
35. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff MS, Gifford N, Schrier RW: The effect of nisoldipine as compared to enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998;338:645-652.
36. Tatti P, Pahor M, Byington RP, DiMauro P, Guarisco R, Strollo G, Strollo F: Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597-603.
37. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (SYST-EUR) Trial. Lancet 1997;350:757-764.
38. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, KH Rahn, Wedel H, Westerling S: Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-1762.